Skip to main content
. 2017 Aug 23;8(14):2809–2815. doi: 10.7150/jca.18286

Table 2.

Chemotherapy regimens including cetuximab.

Regimen MSS (n=147) MSI (n=6)
FOLFIRI/cetuximab 16 (10.9) 2 (33.3)
FOLFOX/cetuximab 13 (8.8)
XELOX/cetuximab 7 (4.8)
XELRI/cetuximab 7 (4.8)
Irinotecan/cetuximab 83 (56.5) 3 (50.0)
Cetuximab 21 (14.3) 1 (16.7)